Study ID: St Jude AML16
A PHASE II TRIAL OF EPIGENETIC PRIMING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
Title: A Phase II Trial of Epigenetic Priming in Patients with Newly Diagnosed Acute Myeloid Leukemia Description: A research study looking at comparing the effects of giving either of two drugs (Azacitidine or Decitabine) before the usual chemotherapy regimen for childhood Acute Myeloid Leukemia (AML).
Fargo Region, Sioux Falls Region
Kayelyn Wagner, MD,Samuel Milanovich, MD
AML (Acute Myelogenic Leukemia)
Active - Open to Accrual